HIV prevention among injection drug users: The need for integrated models

被引:0
|
作者
David S. Metzger
Helen Navaline
机构
[1] HIV Prevention Research Division,University of Pennsylvania Center for Studies of Addiction
关键词
HIV infection; Injection drug users; AIDS; Prevention;
D O I
10.1093/jurban/jtg083
中图分类号
学科分类号
摘要
Opportunistic infections (OIs) were first recognized among injection drug users (IDUs) in New York City in 1981. By the mid-1980s, OIs had become associated with HIV infection, and attention began to focus on efforts to prevent HIV transmission among IDUs. Since then, a range of prevention strategies has been implemented and evaluated in an attempt to reduce the spread of HIV infection among drug users. These prevention strategies include (1) HIV testing and counseling and educational and behavioural interventions delivered through community outreach; (2) condom, bleach, and needle distribution and syringe access and exchange programs: (3) substance abuse treatment; and, more recently, (4) prevention interventions targeting HIV-positive IDUs. Data from evaluations of these strategies over the past 20 years have provided substantial evidence of effectiveness and have helped to inform network-based and structural interventions. Despite the cumulative empirical evidence, however, research findings have yet to be widely, disseminated, adopted, and implemented in a sustained and integrated fashion. The reasons for this are unclear, but point to a need for improved communications with program developers and community planners to facilitate the implementation and evaluation of integrated intervention strategies, and for collaborative research to help understand policy, legal, economic, and local barriers to implementation.
引用
收藏
页码:iii59 / iii66
相关论文
共 50 条
  • [1] HIV prevention among injection drug users: the need for integrated models
    Metzger, DS
    Navaline, H
    JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE, 2003, 80 (04): : 59 - 66
  • [2] HIV treatment as prevention among injection drug users
    Wood, Evan
    Milloy, Michael John
    Montaner, Julio S. G.
    CURRENT OPINION IN HIV AND AIDS, 2012, 7 (02) : 151 - 156
  • [3] Issues of HIV prevention among injection drug users
    Narkevich, E. M.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2010, 110 (05) : 80 - 82
  • [4] HIV prevalence and risks among injection and noninjection drug users in northern Thailand: Need for comprehensive HIV prevention programs
    Razak, MH
    Jittiwutikarn, J
    Suriyanon, V
    Vongchak, T
    Srirak, N
    Beyrer, C
    Kawichai, S
    Tovanabutra, S
    Rungruengthanakit, K
    Sawanpanyalert, P
    Celentano, DD
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 33 (02) : 259 - 266
  • [5] Progress in HIV Reduction and Prevention Among Injection and Noninjection Drug Users
    Crawford, Natalie D.
    Vlahov, David
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2010, 55 : S84 - S87
  • [6] Prevention of HIV among drug users
    Deren, S
    Efthimiou-Mordaunt, A
    Rhodes, F
    Levy, JA
    SUBSTANCE USE & MISUSE, 2002, 37 (8-10) : 1215 - 1227
  • [7] Injection risk behaviors among rural drug users: implications for HIV prevention
    Havens, Jennifer R.
    Oser, Carrie B.
    Leukefeld, Carl G.
    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2011, 23 (05): : 638 - 645
  • [8] Injection and syringe sharing among HIV-infected injection drug users: Implications for prevention of HIV transmission
    Diaz, T
    Chu, SY
    Weinstein, B
    Mokotoff, E
    Jones, TS
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1998, 18 : S76 - S81
  • [9] HIV incidence among injection drug users
    Longshore, D
    Anglin, MD
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1996, 11 (03): : 308 - 309
  • [10] The HIV prevention needs of injection drug users in Estonia
    Wilson, Tracey E.
    Sharma, Anjali
    Zilmer, Kai
    Kalikova, Nelli
    Uuskuela, Anneli
    INTERNATIONAL JOURNAL OF STD & AIDS, 2007, 18 (06) : 389 - 391